These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2814893)
1. Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture model. Shanks MJ; Wiley MJ; Kubow S; Wells PG Teratology; 1989 Oct; 40(4):311-20. PubMed ID: 2814893 [TBL] [Abstract][Full Text] [Related]
2. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture. Miranda AF; Wiley MJ; Wells PG Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268 [TBL] [Abstract][Full Text] [Related]
3. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Winn LM; Wells PG Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765 [TBL] [Abstract][Full Text] [Related]
4. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis. Liu L; Wells PG Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432 [TBL] [Abstract][Full Text] [Related]
5. Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbit. Ozolins TR; Wiley MJ; Wells PG Biochem Pharmacol; 1995 Nov; 50(11):1831-40. PubMed ID: 8615862 [TBL] [Abstract][Full Text] [Related]
6. Evidence for embryonic prostaglandin H synthase-catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo[a]pyrene teratogenesis. Winn LM; Wells PG Free Radic Biol Med; 1997; 22(4):607-21. PubMed ID: 9013124 [TBL] [Abstract][Full Text] [Related]
7. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice. Yu WK; Wells PG Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664 [TBL] [Abstract][Full Text] [Related]
8. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase. Wells PG; Zubovits JT; Wong ST; Molinari LM; Ali S Toxicol Appl Pharmacol; 1989 Feb; 97(2):192-202. PubMed ID: 2493687 [TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. Kim PM; Winn LM; Parman T; Wells PG J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197 [TBL] [Abstract][Full Text] [Related]
10. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant. Liu L; Wells PG Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on the potentiation of phenytoin teratogenicity by acetaminophen. Lum JT; Wells PG Teratology; 1986 Feb; 33(1):53-72. PubMed ID: 3738810 [TBL] [Abstract][Full Text] [Related]
12. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity. Winn LM; Wells PG Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742 [TBL] [Abstract][Full Text] [Related]
13. In vitro murine embryotoxicity of cyclophosphamide in embryos co-cultured with maternal hepatocytes: development and application of a murine embryo-hepatocyte co-culture model. Ozolins TR; Oglesby LA; Wiley MJ; Wells PG Toxicology; 1995 Sep; 102(3):259-74. PubMed ID: 7482566 [TBL] [Abstract][Full Text] [Related]
14. Oxidative damage in chemical teratogenesis. Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860 [TBL] [Abstract][Full Text] [Related]
15. Rat hepatic glutathione S-transferase-mediated embryotoxic bioactivation of ethylene dibromide. Mitra A; Hilbelink DR; Dwornik JJ; Kulkarni A Teratology; 1992 Nov; 46(5):439-46. PubMed ID: 1462248 [TBL] [Abstract][Full Text] [Related]
16. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress. Abramov JP; Wells PG Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394 [TBL] [Abstract][Full Text] [Related]
17. Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro. Harris C; Stark KL; Juchau MR Teratology; 1988 Jun; 37(6):577-90. PubMed ID: 3135633 [TBL] [Abstract][Full Text] [Related]
18. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice. Kasapinovic S; McCallum GP; Wiley MJ; Wells PG Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029 [TBL] [Abstract][Full Text] [Related]
19. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Wong M; Wells PG J Pharmacol Exp Ther; 1989 Jul; 250(1):336-42. PubMed ID: 2746506 [TBL] [Abstract][Full Text] [Related]
20. In vitro development of the mammalian embryo. Sanyal MK; Naftolin F J Exp Zool; 1983 Nov; 228(2):235-51. PubMed ID: 6420506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]